Concepedia

Second Malignancy Risk Reduction

Second Malignancy Risk Reduction is a preventive oncology strategy that specifically targets the reduction of the incidence or likelihood of new primary cancers in cancer survivors through targeted interventions, surveillance, or modification of treatment-related or lifestyle risk factors.

100

Publications

6K

Citations

663

Authors

273

Institutions

Publications per year

2017–2026

15

Parents

Publications

100

Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast Cancer

Umberto Veronesi, G. De Palo, Ettore Marubini et al. · JNCI Journal of the National Cancer Institute · 1999 · 421 citations · Full text

, , +13

Randomized Phase III Trial of Low-dose Isotretinoin for Prevention of Second Primary Tumors in Stage I and II Head and Neck Cancer Patients

Fadlo R. Khuri, Scott M. Lippman, Edward S. Kim et al. · JNCI Journal of the National Cancer Institute · 2006 · 238 citations

, , +11

Risk of second cancer among women with breast cancer

Lene Mellemkjær, Søren Friis, Jørgen H. Olsen et al. · International Journal of Cancer · 2005 · 231 citations · Full text

, , +11

Life Expectancy Gains From Cancer Prevention Strategies for Women With Breast Cancer and <EMPH TYPE="ITAL">BRCA1</EMPH> or <EMPH TYPE="ITAL">BRCA2</EMPH> Mutations

Deborah Schrag · JAMA · 2000 · 220 citations

, , +17

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer

Umberto Veronesi, Luigi Mariani, Andrea DeCensi et al. · Annals of Oncology · 2006 · 216 citations · Full text

, , +8

1–5 of 100

Authors

663

  1. AD
    Andrea DeCensi

    European Institute of Oncology, Italy

    4 publications · 770 citations

    4

    h-index

  2. TC
    Tiziana Camerini

    Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

    4 publications · 771 citations

    4

    h-index

  3. MG
    Maria Gaetana Di Mauro

    Fondazione IRCCS Istituto Nazionale dei Tumori, Italy

    4 publications · 771 citations

    4

    h-index

  4. UV
    Umberto Veronesi

    European Institute of Oncology, Italy

    4 publications · 576 citations

    4

    h-index

  5. AC
    Alberto Costa

    European Institute of Oncology, Italy

    3 publications · 155 citations

    3

    h-index

1–5 of 663

Institutions

273

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    7 h-index

    51 publications

    4.8K citations

  2. Dana-Farber Cancer Institute

    Boston, United States

    6 h-index

    35 publications

    3.1K citations

  3. Harvard University

    Cambridge, United States

    5 h-index

    13 publications

    352 citations

  4. European Institute of Oncology

    Milan, Italy

    5 h-index

    32 publications

    9.4K citations

  5. Danish Cancer Society

    Copenhagen, Denmark

    4 h-index

    10 publications

    997 citations

  6. Heidelberg University

    Heidelberg, Germany

    4 h-index

    15 publications

    2K citations

  7. Finnish Cancer Registry

    Helsinki, Finland

    3 h-index

    4 publications

    419 citations

  8. National Yang Ming Chiao Tung University

    Hsinchu, Taiwan

    3 h-index

    22 publications

    1.1K citations

1–8 of 273

Venues

  1. 7

    h-index

  2. European Journal of Cancer

    6 publications · 251 citations

    6

    h-index

  3. Annals of Oncology

    5 publications · 594 citations

    5

    h-index

  4. Radiotherapy and Oncology

    4 publications · 263 citations

    4

    h-index

  5. JNCI Journal of the National Cancer Institute

    4 publications · 910 citations

    4

    h-index

1–5